Lisata Therapeutics, Inc.
LSTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,985 | -$20,840 | -$54,225 | -$27,466 |
| Dep. & Amort. | $174 | $189 | $69 | $55 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,653 | $2,038 | $2,636 | $2,005 |
| Change in WC | -$873 | -$462 | -$831 | $647 |
| Other Non-Cash | -$325 | -$957 | $31,181 | $2,514 |
| Operating Cash Flow | -$19,356 | -$20,032 | -$21,170 | -$22,245 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$285 | -$60 |
| Net Acquisitions | -$130 | $0 | -$3,320 | $55 |
| Inv. Purchases | -$55,688 | -$98,479 | -$89,687 | -$179,775 |
| Inv. Sales/Matur. | $69,051 | $108,581 | $122,203 | $124,939 |
| Other Inv. Act. | $0 | $0 | $0 | -$55 |
| Investing Cash Flow | $13,233 | $10,102 | $28,911 | -$54,896 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $68 | $321 | $43 | $85,500 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$274 | $64 | -$267 | -$224 |
| Financing Cash Flow | -$206 | $385 | -$224 | $85,276 |
| Forex Effect | -$55 | -$16 | -$10 | $0 |
| Net Chg. in Cash | -$6,384 | -$9,561 | $7,507 | $8,135 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,593 | $32,154 | $24,647 | $16,512 |
| End Cash | $16,209 | $22,593 | $32,154 | $24,647 |
| Free Cash Flow | -$19,356 | -$20,032 | -$21,455 | -$22,305 |